D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Biogen
BIIB
|
+$458M |
| 2 |
Apple
AAPL
|
+$445M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$417M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$245M |
| 5 |
Union Pacific
UNP
|
+$221M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$669M |
| 2 |
Meta Platforms (Facebook)
META
|
+$478M |
| 3 |
Marathon Petroleum
MPC
|
+$469M |
| 4 |
Valero Energy
VLO
|
+$456M |
| 5 |
DuPont de Nemours
DD
|
+$451M |
Sector Composition
| 1 | Healthcare | 16.27% |
| 2 | Communication Services | 11.84% |
| 3 | Technology | 11.37% |
| 4 | Energy | 10.36% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
1801
DELISTED
Natus Medical Inc
NTUS
| $875K | ﹤0.01% |
18,207
-2,081
| -10% | -$100K |
|
|
DBVT
1802
DBV Technologies
DBVT
$260M
| $873K | ﹤0.01% |
2,405
-1,053
| -30% | -$382K |
|
|
HIMX
1803
Himax Technologies
HIMX
$1.47B
| $867K | ﹤0.01% |
105,676
+52,909
| +100% | +$434K |
|
|
MFA
1804
MFA Financial
MFA
$1.05B
| $866K | ﹤0.01% |
+32,779
| New | +$866K |
|
|
JAH
1805
DELISTED
JARDEN CORPORATION
JAH
| $865K | ﹤0.01% |
15,142
-34,390
| -69% | -$1.96M |
|
|
CTT
1806
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $864K | ﹤0.01% |
76,356
-13,392
| -15% | -$152K |
|
|
TTPH
1807
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $861K | ﹤0.01% |
4,294
+2,446
| +132% | +$490K |
|
|
ESL
1808
DELISTED
Esterline Technologies
ESL
| $861K | ﹤0.01% |
+10,625
| New | +$861K |
|
|
PRTY
1809
DELISTED
Party City Holdco Inc.
PRTY
| $860K | ﹤0.01% |
66,600
+36,866
| +124% | +$476K |
|
1810
Diamondback Energy
FANG
$40.4B
| $858K | ﹤0.01% |
12,823
-209,807
| -94% | -$14M |
|
1811
New Mountain Finance
NMFC
$1.11B
| $858K | ﹤0.01% |
65,925
-4,593
| -7% | -$59.8K |
|
|
SWFT
1812
DELISTED
Swift Transportation Company
SWFT
| $858K | ﹤0.01% |
62,071
+34,651
| +126% | +$479K |
|
1813
Broadridge
BR
$29.3B
| $857K | ﹤0.01% |
15,958
-58,151
| -78% | -$3.12M |
|
1814
First Busey Corp
BUSE
$2.19B
| $855K | ﹤0.01% |
41,451
+28,001
| +208% | +$578K |
|
|
FGL
1815
DELISTED
Fidelity & Guaranty Life
FGL
| $854K | ﹤0.01% |
33,664
-43,239
| -56% | -$1.1M |
|
1816
KT
KT
$9.52B
| $853K | ﹤0.01% |
71,584
-34,803
| -33% | -$415K |
|
1817
Vaalco Energy
EGY
$416M
| $852K | ﹤0.01% |
532,305
+21,809
| +4% | +$34.9K |
|
|
CAMP
1818
DELISTED
CalAmp Corp.
CAMP
| $851K | ﹤0.01% |
+1,857
| New | +$851K |
|
1819
Fulton Financial
FULT
$3.51B
| $848K | ﹤0.01% |
65,216
-32,677
| -33% | -$425K |
|
1820
Haverty Furniture Companies
HVT
$380M
| $845K | ﹤0.01% |
39,423
-4,996
| -11% | -$107K |
|
|
MYCC
1821
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $842K | ﹤0.01% |
46,076
+10,242
| +29% | +$187K |
|
1822
Ross Stores
ROST
$48.8B
| $841K | ﹤0.01% |
15,617
-56,493
| -78% | -$3.04M |
|
1823
Verastem
VSTM
$608M
| $841K | ﹤0.01% |
+37,691
| New | +$841K |
|
|
EXAR
1824
DELISTED
Exar Corporation
EXAR
| $840K | ﹤0.01% |
137,087
+35,603
| +35% | +$218K |
|
|
JUNO
1825
DELISTED
Juno Therapeutics, Inc.
JUNO
| $839K | ﹤0.01% |
19,086
-8,347
| -30% | -$367K |
|